Descriptive Study on Guillain Barré Syndrome

Guillain-Barré Syndrome (GBS) is an acute, immune-mediated poly radiculo neuropathy that primarily affects the peripheral nervous system. It often presents with rapidly progressing muscle weakness, areflexia, and, in severe cases, respiratory failure. The syndrome is commonly preceded by an infection, such as Campylobacter jejuni, and is believed to result from molecular mimicry, where the immune response to the infection cross-reacts with peripheral nerve components. Diagnosis is primarily clinical, supported by cerebrospinal fluid analysis and nerve conduction studies. Treatment typically includes intravenous immunoglobulin (IVIG) or plasmapheresis, with most patients showing significant recovery over time. Early diagnosis and prompt management are crucial in reducing morbidity and mortality. This review highlights the pathophysiology, clinical features, diagnosis, and current treatment strategies of GBS.